Bioequivalence of Cagrilintide B + placebo semaglutide I and Cagrilintide D formulations to be assessed in overweight/obese adults
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
Study Design
Population
234 adults with overweight or obesity.
Intervention
Cagrilintide B (with placebo semaglutide I) over 17 weeks.
Comparator
Cagrilintide D formulation.
Outcome
Blood levels of Cagrilintide B and Cagrilintide D.
Abstract
Phase 1 trial to compare Cagrilintide B (with placebo semaglutide I) and Cagrilintide D blood levels in 234 adults with overweight or obesity over 17 weeks.